Ayad Abdul-Ahad
CEO
BOTh Analytics GmbH and A3 Pharma Counselling
Germany
Biography
After obtaining his medical degree, Ayad continued his speciality training in the UK in Immunology and Oncology. He obtained, the PhD, MSC, MRCPath and FRCPath. His areas of interest included Immunotherapy and BMT. Over the past 24 years he worked in the Biopharmaceutical industry, across the US and Europe, during which he built and lead Medical Affairs and Clinical Development in companies, such as Serono, Berlex, Biogen and Astellas. Ayad also pioneered cancer immunotherapy by treating the first ever patient with a therapeutic antibody for cancer. He is regarded as a Medical Leader by the World leading experts in MS
Research Interest
His areas of interest included Immunotherapy and BMT.